Chromosome 6p21.2, 18q21.2 and human papilloma virus (HPV) DNA can predict prognosis of cervical cancer after radiotherapy

International Journal of Cancer

Volumn 96, Issue 5, 2001, Pages 286-296

  Harima, Yoko ^a   Sawada, Satoshi ^a   Nagata, Kenji ^a   Sougawa, Mitsuharu ^a   Ohnishi, Takeo ^b  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

18q; 6p; Cervical cancer; HPV; Loss of heterozygosity

Indexed keywords

PROTEIN P53; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHROMOSOME 18Q; CHROMOSOME 3P; CHROMOSOME 6P; CONSENSUS SEQUENCE; FEMALE; GENE INACTIVATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 6; DISEASE-FREE SURVIVAL; DNA, VIRAL; FEMALE; GENES, P53; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0035922878     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1027     Document Type: Article

References (56)

1. Strategies for global control of cervical cancer
2. Postsurgical recurrent carcinoma of the cervix: Reassessment and results of radiation therapy options
3. Human papilloma vires has no prognostic significance in cervical carcinoma
4. Human papillomavirus type 18: Association with poor prognosis in early stage cervical cancer
5. Allelic loss of chromosome 13q14.3 in human oral cancer: Correlation with lymph node metastasis
6. Allelic loss on chromosome 10q in human lung cancer: Association with tumour progression and metastatic phenotype
7. Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis
8. Chromosome changes in 43 carcinomas of the cervix uteri
9. Deletion mapping of chromosome 3p in female genital tract malignancies using microsatellite polymorphisms
10. Deletion mapping of chromosome 3p in human uterine cervical cancer
11. Allelotyping of all chromosomal arms in invasive cervical cancer
12. Allelic loss and prognosis in carcinoma of the uterine cervix
13. Loss of heterozygosity on chromosome 6p21.2 as a potential marker for recurrence after radiotherapy of human cervical cancer
14. Allelotype analysis of cervical carcinoma
15. Genomic alterations in cervical carcinoma: Losses of chromosome heterozygosity and human papilloma virus tumor status
16. Genetic alterations on chromosome 17p associated with response to radiotherapy in bulky cervical cancer
17. Detection of genital human papillomavirus infection using PCR
18. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction
19. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix
20. The state of p53 in primary human cervical carcinomas and its effects in human papillomavirusimmortalized human cervical cells
21. A comprehensive genetic map of the human genome based on 5,264 microsatellite
22. Nonparametric estimation from incomplete observations
23. Evaluation of survival data and two new rank order statistics arising in its consideration
24. Regression models and life-tables
25. New direction for radiation biology research in cancer of the uterine cervix
26. Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness
27. Micronucleus assay in three transplantable mouse tumors
28. Manganese superoxide dismutase expression correlates with p53 status and local recurrence of cervical carcinoma treated with radiation therapy
29. Allelotype of colorectal carcinomas
30. Cytogenetics of non-small cell lung cancer: Analysis of consistent non-random abnormalities
31. A mutant p21 cyclindependent kinase inhibitor isolated from a Burkitt's lymphoma
32. Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer
33. Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations
34. Polymorphism of the WAF1 gene is related to susceptibility of cervical cancer in Japanese women
35. Absence of WAF1 mutations in a variety of human malignancies
36. Allelic loss of chromosome 18q and prognosis in colorectal cancer
37. Current status of adjuvant chemotherapy for colorectal cancer: Can molecular markers play a role in predicting prognosis?
38. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
39. Analysis of the DPC4 gene in gastric carcinoma
40. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
41. Human papillomavirus in vulvar squamous-cell carcinoma and in normal vulvar tissues: A search for a possible impact of HPV on vulvar cancer prognosis
42. Prognostic significance of human papillomavirus DNA in vulvar carcinoma
43. Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survival
44. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product
45. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
46. Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: Repression of E6/E7-oncogene expression and induction of apoptosis
47. Mutation in the DNA mismatch repair gene homologue hMLH-1 is associated with hereditary non-polyposis colon cancer
48. Localization of the human beta-catenin gene (CTNNB1) to 3p21: A region implicated in tumor development
49. Yeast artificial chromosome cloning of the beta-catenin locus on human chromosome 3p21-22
50. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix
51. Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: Frequent loss of heterozygosity on chromosome arms 3p, 9q, 10q, and 17p
52. Implications of the p53 tumor-suppressor gene in clinical oncology
53. Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
54. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: A Southwest Oncology Group study
55. p53 mutations in HPV-negative cervical carcinoma